After admitting mistake, AstraZeneca faces difficult questions about its coronavirus vaccine

Since unveiling the preliminary results, AstraZeneca has acknowledged a key mistake in the vaccine dosage received by some study participants, adding to questions about whether the vaccine’s apparently spectacular efficacy will hold up under additional testing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3l9KChY
via IFTTT